Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Article Dans Anglais | IMSEAR | ID: sea-156691

Résumé

Esthetics is of prime concern when replacing any anterior tooth. The prosthesis should resemble the adjacent natural tooth closely. Out of many types of pontic designs, ovate pontic may serve the purpose of providing good esthetics and phonetics. It will maintain interdental papilla and help to maintain good gingival health. In addition to it ovate pontic has an advantage of immediately replacing the missing anterior tooth.

2.
Article Dans Anglais | IMSEAR | ID: sea-135887

Résumé

Background & objective: Recombinant DNA technology allows expression of the human papillomavirus (HPV) major capsid protein (L1) in heterologous expression systems and the recombinant protein self assembles to virus-like particles (VLP). We took up this study to produce recombinant HPV-16 L1 in yeast, establish the process of recombinant L1 derived VLP preparation and develop an ELISA using VLP as the antigen for serological evaluation of anti HPV-16 L1 antibody status. Methods: Complete HPV-16 L1 was amplified from genomic DNA of an esophageal cancer biopsy, cloned and the protein was expressed in a galactose-inducible Saccharomyces cerevisiae expression system. Self assembled VLP was purified by a two-step density gradient centrifugation process and the VLP preparation used to test its suitability in developing an ELISA. Results: The recombinant protein was predominantly a ~55 KD species with distinct immunoreactivity and formed VLP as confirmed by electron microscopy. An ELISA using the VLP showed its efficacy in appropriate immunoreactivity to serum/plasma IgG. Interpretation & conclusions: Recombinant HPV-16 capsid protein derived VLP was produced and the VLP antigen based ELISA can be used to probe serological association of HPV with different clinical conditions. The VLP technology can be improved further and harnessed for future vaccine development efforts in the country.


Sujets)
Anticorps antiviraux/analyse , Antigènes viraux/biosynthèse , Antigènes viraux/génétique , Protéines de capside/biosynthèse , Protéines de capside/génétique , Protéines de capside/immunologie , Test ELISA , Papillomavirus humain de type 16/génétique , Papillomavirus humain de type 16/immunologie , Papillomavirus humain de type 16/ultrastructure , Humains , Protéines des oncogènes viraux/biosynthèse , Protéines des oncogènes viraux/génétique , Protéines des oncogènes viraux/immunologie , Protéines recombinantes/biosynthèse , Protéines recombinantes/génétique , Protéines recombinantes/immunologie , Saccharomyces cerevisiae/génétique
SÉLECTION CITATIONS
Détails de la recherche